TXMD vs USB · rev $1.8M vs P/E 12, rev $28.66B
TherapeuticsMD Inc (TXMD) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
TXMD currently screens at market cap $13.7M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the TXMD and USB stock pages for the full models.
Not investment advice.